Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page

Applying Cervical Cancer Screening Guidelines to Clinical Practice

On Demand Sessions:

Expiration Date Presenter Are you seeking credit?
October 14, 2017 Ina Park, MD, MS Review webinar for CME/CE credit*

Review webinar without credit

October 28, 2017 Rebecca Perkins, MD, MSc
*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.

This is a one-hour internet-based activity. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.

Learning Objectives

By the end of this webinar, participants will be able to:

  • Describe the natural history of human papillomavirus and the development of cervical cancer.
  • Understand the difference between transient and persistent infection.
  • Explain the rationale for an extended screening interval for cervical cancer.
  • Describe the elements of an annual Well Woman visit that does not include an annual Pap test.
  • Apply knowledge of cervical cancer screening to the management of various test results.
  • Explain how the Affordable Care Act may increase opportunities for women to receive screening for cervical cancer.

Accreditation Information

Continuing Medical Education Credits: ARHP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Credits: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. Applying Cervical Cancer Screening Guidelines to Clinical Practice is approved for 1.0 contact hours.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project and webinar is funded through educational grants from Roche Pharma.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

  • Lee Shulman, MD (Program planner and faculty) is speaker and/or consultant for Actavis, Teva, Merck, Bayer, Shionogi, Sequenom, Natera, Quest, and Roche Labs.
  • Nancy R. Berman, MSN, ANP-BC, NCMP (Planner) is a speaker for QIAGEN and a consultant for Hologic.
  • Diane W. Shannon, MD (medical writer) has nothing to disclose.
  • Rana Suliman, MPH (ARHP staff) has nothing to disclose.